Go Pro

Climb Bio (CLYM) Institutional Ownership

Climb Bio logo
$12.70 +0.12 (+0.95%)
Closing price 07/17/2026 04:00 PM Eastern
Extended Trading
$12.68 -0.01 (-0.12%)
As of 07/17/2026 07:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Climb Bio (NASDAQ:CLYM)

Current
Institutional Ownership
Percentage
69.76%
Number of
Institutional Buyers
(last 12 months)
38
Total
Institutional Inflows
(last 12 months)
$34.07M
Number of
Institutional Sellers
(last 12 months)
15
Total
Institutional Outflows
(last 12 months)
$96.61M
Get CLYM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Climb Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CLYM Institutional Buying and Selling by Quarter

Climb Bio Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/4/2026Seven Fleet Capital Management LP130,654$895K0.3%+71.0%0.228%
5/19/2026Bank of America Corp DE52,921$363K0.0%+945.2%0.092%
5/18/2026ADAR1 Capital Management LLC597,662$4.09M0.2%-58.3%1.044%
5/16/2026The Manufacturers Life Insurance Company 156,317$1.07M0.0%+11.2%0.273%
5/15/2026OMERS ADMINISTRATION Corp16,700$114K0.0%-80.5%0.029%
5/15/2026Affinity Asset Advisors LLC700,000$4.80M0.2%-46.2%1.222%
5/14/2026Renaissance Technologies LLC217,300$1.49M0.0%-32.2%0.379%
5/7/2026Dimensional Fund Advisors LP104,437$715K0.0%N/A0.219%
3/20/2026Hsbc Holdings PLC24,744$99K0.0%+107.2%0.052%
2/26/2026Seven Fleet Capital Management LP76,400$306K0.2%N/A0.112%
2/23/2026Virtu Financial LLC10,655$43K0.0%N/A0.016%
2/18/2026XTX Topco Ltd34,852$139K0.0%+19.4%0.051%
2/18/2026Squadron Capital Management LLC100,000$400K0.2%N/A0.147%
2/18/2026Sphera Funds Management LTD.932,247$3.73M0.7%+114.4%1.367%
2/18/2026Millennium Management LLC296,314$1.19M0.0%-37.2%0.435%
2/18/2026Balyasny Asset Management L.P.14,236$57K0.0%N/A0.021%
2/18/2026Bridgeway Capital Management LLC159,300$637K0.0%+45.7%0.234%
2/18/2026683 Capital Management LLC201,652$807K0.0%N/A0.296%
2/17/2026ADAR1 Capital Management LLC1,432,475$5.73M0.4%+972.8%2.101%
2/17/2026MPM Bioimpact LLC2,671,480$10.69M1.2%N/A3.918%
2/17/2026RA Capital Management L.P.11,293,828$45.18M0.5%-64.1%16.565%
2/17/2026Kotler Kevin400,000$1.60M0.4%N/A0.587%
2/17/2026Price T Rowe Associates Inc. MD1,923,639$7.70M0.0%+265.1%2.821%
2/17/2026Blair William & Co. IL11,000$44K0.0%N/A0.016%
2/17/2026Persistent Asset Partners Ltd9,228$37K0.0%-67.3%0.014%
2/16/2026OMERS ADMINISTRATION Corp85,466$342K0.0%N/A0.125%
2/16/2026ArchPoint Investors121,400$486K0.1%N/A0.178%
2/16/2026Barclays PLC61,853$247K0.0%+149.9%0.091%
2/13/2026Marshall Wace LLP304,015$1.22M0.0%+32.2%0.446%
2/13/2026The Manufacturers Life Insurance Company 140,617$567K0.0%+261.5%0.206%
2/13/2026Hudson Bay Capital Management LP48,736$195K0.0%N/A0.071%
2/13/2026State Street Corp128,900$516K0.0%+25.0%0.189%
2/12/2026Jane Street Group LLC187,403$750K0.0%+135.3%0.275%
2/12/2026Renaissance Technologies LLC320,600$1.28M0.0%-40.3%0.470%
2/10/2026TD Asset Management Inc246,200$985K0.0%+175.4%0.361%
2/10/2026Goldman Sachs Group Inc.224,883$900K0.0%+205.1%0.330%
1/30/2026Citizens Financial Group Inc. RI28,168$113K0.0%-38.8%0.041%
1/28/2026Peapod Lane Capital LLC565,992$2.26M1.9%+0.7%0.830%
1/1/2026JPMorgan Chase & Co.22,012$44K0.0%-89.5%0.032%
11/17/2025Susquehanna International Group LLP142,450$286K0.0%+128.4%0.209%
Buy this stock today (Ad)

Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.tc pixel

Get the name, ticker, and full Hotlist before markets open
11/17/2025Prelude Capital Management LLC40,718$82K0.0%N/A0.060%
11/17/2025Millennium Management LLC471,704$948K0.0%-1.7%0.692%
11/14/2025Deep Track Capital LP509,789$1.03M0.0%-51.0%0.748%
11/14/2025ADAR1 Capital Management LLC133,530$268K0.0%+11.9%0.196%
11/14/2025Shay Capital LLC150,000$302K0.0%-63.9%0.220%
11/14/2025Two Sigma Investments LP112,681$226K0.0%-37.3%0.165%
11/14/2025Bridgeway Capital Management LLC109,300$220K0.0%-18.6%0.160%
11/13/2025UBS Group AG405,404$815K0.0%+6.0%0.595%
11/10/2025Peapod Lane Capital LLC561,866$1.13M1.0%+1.1%0.824%
11/10/2025Persistent Asset Partners Ltd28,221$57K0.0%-80.6%0.041%
11/7/2025Vanguard Group Inc.1,315,811$2.65M0.0%-1.2%1.942%
11/7/2025JPMorgan Chase & Co.22,012$44K0.0%-89.5%0.032%
10/31/2025Vanguard Personalized Indexing Management LLC14,546$29K0.0%N/A0.021%
10/24/2025Citizens Financial Group Inc. RI46,000$92K0.0%N/A0.068%
8/15/2025Shay Capital LLC415,000$515K0.1%+107.5%0.612%
8/14/2025Jane Street Group LLC148,180$184K0.0%N/A0.219%
8/14/2025Diadema Partners LP702,135$871K0.3%+4.8%1.039%
8/14/2025Qube Research & Technologies Ltd34,310$43K0.0%N/A0.051%
8/13/2025Marshall Wace LLP36,738$46K0.0%N/A0.054%
8/13/2025Stonepine Capital Management LLC116,147$144K0.1%N/A0.172%
8/12/2025JPMorgan Chase & Co.210,122$261K0.0%-31.4%0.311%
8/8/2025Geode Capital Management LLC311,721$387K0.0%-53.7%0.461%
8/8/2025Nan Fung Trinity HK Ltd.463,654$575K0.1%N/A0.686%
8/1/2025 Y Intercept Hong Kong Ltd127,952$159K0.0%N/A0.189%
6/27/2025Goldman Sachs Group Inc.120,742$147K0.0%N/A0.179%
5/16/2025Goldman Sachs Group Inc.120,742$147K0.0%N/A0.179%
5/16/2025AQR Capital Management LLC21,808$27K0.0%N/A0.032%
5/16/2025Allostery Investments LP244,988$299K0.4%N/A0.363%
5/16/2025ADAR1 Capital Management LLC119,320$146K0.0%N/A0.177%
5/15/2025RA Capital Management L.P.31,419,267$38.33M0.6%N/A46.495%
5/14/2025Affinity Asset Advisors LLC1,500,000$1.83M0.2%N/A2.220%
5/13/2025Persistent Asset Partners Ltd145,760$178K0.1%N/A0.216%
5/12/2025Nuveen LLC39,034$48K0.0%N/A0.058%
5/9/2025Charles Schwab Investment Management Inc.70,093$86K0.0%N/A0.104%
5/8/2025XTX Topco Ltd27,660$34K0.0%N/A0.041%
5/7/2025TD Asset Management Inc89,400$109K0.0%N/A0.132%
4/30/2025Peapod Lane Capital LLC553,816$676K0.8%N/A0.821%
4/29/2025Bank of New York Mellon Corp64,914$79K0.0%N/A0.096%


CLYM Institutional Ownership - Frequently Asked Questions

During the previous two years, 53 institutional investors and hedge funds held shares of Climb Bio. The most heavily invested institutionals were RA Capital Management L.P. ($45.18M), MPM Bioimpact LLC ($10.69M), Price T Rowe Associates Inc. MD ($7.70M), Affinity Asset Advisors LLC ($4.80M), ADAR1 Capital Management LLC ($4.09M), Sphera Funds Management LTD. ($3.73M), and Vanguard Group Inc. ($2.65M).Learn more on Climb Bio's institutional investors.

69.76% of Climb Bio's stock is owned by institutional investors. Learn more on CLYM's institutional investor holdings.

Of the 46 institutional investors that purchased Climb Bio's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($31.42M), MPM Bioimpact LLC ($2.67M), Affinity Asset Advisors LLC ($1.50M), ADAR1 Capital Management LLC ($1.43M), Price T Rowe Associates Inc. MD ($1.40M), Peapod Lane Capital LLC ($564.14K), and Sphera Funds Management LTD. ($497.41K).

Institutional investors have bought a total of 9,282,405 shares in the last 24 months. This purchase volume represents approximately $34.07M in transactions.

Of the 15 institutional investors that sold Climb Bio's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: RA Capital Management L.P. ($20.13M), ADAR1 Capital Management LLC ($834.81K), Affinity Asset Advisors LLC ($600K), Deep Track Capital LP ($530.33K), JPMorgan Chase & Co. ($472.52K), Geode Capital Management LLC ($362.09K), and Renaissance Technologies LLC ($319.80K).

Institutional investors have sold a total of 24,023,652 shares in the last 24 months. This volume of shares sold represents approximately $96.61M in transactions.



This page (NASDAQ:CLYM) was last updated on 7/19/2026 by MarketBeat.com Staff.
From Our Partners